Furthermore, IHC staining of COL11A1 protein in tumour tissue sections from two EOC patients with chemoresistant disease showed that the percentage of tumour cells stained positive for COL11A1 and the intensity of COL11A1 staining markedly increased after chemotherapy compared to those at initial diagnosis (Fig. 6B). This evidence concerns the gene COL11A1 and neoplasm.